Edith A. Perez

Edith A. Perez, M.D., is an internationally renowned hematologist-oncologist and thought leader committed to advancing cancer drug development and improving patient care through health equity and access to innovative treatments. Dr. Perez is a highly respected leader and role model for future generations, with over 700 peer-reviewed authored or co-authored manuscripts and abstracts , reflected by her frequent invitations to lecture at national and international meetings as well as serving on the board of multiple academic journals and holding leadership and advisory positions across academic, clinical, and industry settings, including Professor Emeritus at [https://www.mayoclinic.org/ Mayo Clinic]. Provided by Wikipedia
Showing 1 - 20 results of 22 for search 'Edith A. Perez', query time: 0.07s Refine Results
  1. 1
    Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries.

    Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries. by Wenjie Zhu, Edith A Perez, Ruoxi Hong, Qing Li, Binghe Xu

    Published 2015-01-01
    Get full text
    Article
  2. 2
    Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1

    Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1 by Jing Yang, Edith A. Perez, Changchun Hou, Pin Zhang, Michelle Van Scoyk, Robert A. Winn, Lijun Rong, Jing Liu

    Published 2021-07-01
    Get full text
    Article
  3. 3
    Increased Incidence of Loco-Regional Recurrences among African American Women with Terminal Stage Breast Cancer

    Increased Incidence of Loco-Regional Recurrences among African American Women with Terminal Stage Breast Cancer by Gerardo Colón-Otero M.D., Sherry King, Vandelyn Smith, Carolyn Bieber, Julia Crook, Lawrence A. Solberg, Robert Shannon, Edith A. Perez

    Published 2008-01-01
    Get full text
    Article
  4. 4
    720 A phase 1/2 study of BDC-3042, a novel Dectin-2 agonistic antibody, in patients with advanced cancers

    720 A phase 1/2 study of BDC-3042, a novel Dectin-2 agonistic antibody, in patients with advanced cancers by Edith A Perez, Lu Xu, Antonio Giordano, Justin Kenkel, Shelley E Ackerman, Michael N Alonso, Sharon Wilks, Aparna R Parikh, Danlin Cai, Damon Demady

    Published 2023-11-01
    Article
  5. 5
    Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases

    Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases by Kurt A. Jaeckle, Jesse G. Dixon, Stephen Keith Anderson, Alvaro Moreno‐Aspitia, Gerardo Colon‐Otero, Kathy Hebenstreit, Tejal A. Patel, Samarth L. Reddy, Edith A. Perez

    Published 2020-11-01
    Get full text
    Article
  6. 6
    Analysis of Population Differences in Digital Conversations About Cancer Clinical Trials: Advanced Data Mining and Extraction Study

    Analysis of Population Differences in Digital Conversations About Cancer Clinical Trials: Advanced Data Mining and Extraction Study by Edith A Perez, Elizabeth M Jaffee, John Whyte, Cheryl A Boyce, John D Carpten, Guillermina Lozano, Raymond M Williams, Karen M Winkfield, David Bernstein, Sung Poblete

    Published 2021-09-01
    Get full text
    Article
  7. 7
    Breast Cancer Clinical Trial of Chemotherapy and Trastuzumab: Potential Tool to Identify Cardiac Modifying Variants of Dilated Cardiomyopathy

    Breast Cancer Clinical Trial of Chemotherapy and Trastuzumab: Potential Tool to Identify Cardiac Modifying Variants of Dilated Cardiomyopathy by Daniel J. Serie, Julia E. Crook, Brian M. Necela, Bianca C. Axenfeld, Travis J. Dockter, Gerardo Colon-Otero, Edith A. Perez, E. Aubrey Thompson, Nadine Norton

    Published 2017-05-01
    Get full text
    Article
  8. 8
    Impact of library preparation on downstream analysis and interpretation of RNA-Seq data: comparison between Illumina PolyA and NuGEN Ovation protocol.

    Impact of library preparation on downstream analysis and interpretation of RNA-Seq data: comparison between Illumina PolyA and NuGEN Ovation protocol. by Zhifu Sun, Yan W Asmann, Asha Nair, Yuji Zhang, Liguo Wang, Krishna R Kalari, Aditya V Bhagwate, Tiffany R Baker, Jennifer M Carr, Jean-Pierre A Kocher, Edith A Perez, E Aubrey Thompson

    Published 2013-01-01
    Get full text
    Article
  9. 9
    821 The combination of a trastuzumab ISAC and pertuzumab augments anti-tumor efficacy in multiple HER2+ tumor models relative to trastuzumab plus pertuzumab

    821 The combination of a trastuzumab ISAC and pertuzumab augments anti-tumor efficacy in multiple HER2+ tumor models relative to trastuzumab plus pertuzumab by Edith A Perez, Andrew Luo, Anthony Lucas, Han K Kim, Paul D Ponath, Katelynn A McEachin, Karla A Henning, Shelley E Ackerman, Steven J Chapin, Michael N Alonso, Cecelia I Pearson, David Omstead

    Published 2023-11-01
    Article
  10. 10
    Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing.

    Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing. by Zhifu Sun, Yan W Asmann, Krishna R Kalari, Brian Bot, Jeanette E Eckel-Passow, Tiffany R Baker, Jennifer M Carr, Irina Khrebtukova, Shujun Luo, Lu Zhang, Gary P Schroth, Edith A Perez, E Aubrey Thompson

    Published 2011-01-01
    Get full text
    Article
  11. 11
    Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer

    Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positi... by Edith A. Perez, Sanne Lysbet de Haas, Wolfgang Eiermann, Carlos H. Barrios, Masakazu Toi, Young-Hyuck Im, Pier Franco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier B. Pivot, Howard A. Burris, Sven Stanzel, Monika Patre, Paul Anthony Ellis

    Published 2019-06-01
    Get full text
    Article
  12. 12
    Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer

    Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer by Nadine Norton, Nicholas Fox, Christie-Ann McCarl, Kathleen S. Tenner, Karla Ballman, Courtney L. Erskine, Brian M. Necela, Donald Northfelt, Winston W. Tan, Carmen Calfa, Mark Pegram, Gerardo Colon-Otero, Edith A. Perez, Raphael Clynes, Keith L. Knutson

    Published 2018-06-01
    Get full text
    Article
  13. 13
    Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors.

    Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors. by Nadine Norton, Pooja P Advani, Daniel J Serie, Xochiquetzal J Geiger, Brian M Necela, Bianca C Axenfeld, Jennifer M Kachergus, Ryan W Feathers, Jennifer M Carr, Julia E Crook, Alvaro Moreno-Aspitia, Panos Z Anastasiadis, Edith A Perez, E Aubrey Thompson

    Published 2016-01-01
    Get full text
    Article
  14. 14
    miR-221-5p-Mediated Downregulation of JNK2 Aggravates Acute Lung Injury

    miR-221-5p-Mediated Downregulation of JNK2 Aggravates Acute Lung Injury by Jing Yang, Hanh Chi Do-Umehara, Qiao Zhang, Huashan Wang, Changchun Hou, Huali Dong, Edith A. Perez, Marc A. Sala, Kishore R. Anekalla, James M. Walter, Shuwen Liu, Shuwen Liu, Richard G. Wunderink, Richard G. Wunderink, G.R. Scott Budinger, Jing Liu

    Published 2021-11-01
    Get full text
    Article
  15. 15
    Folate receptor-α (FOLR1) expression and function in triple negative tumors.

    Folate receptor-α (FOLR1) expression and function in triple negative tumors. by Brian M Necela, Jennifer A Crozier, Cathy A Andorfer, Laura Lewis-Tuffin, Jennifer M Kachergus, Xochiquetzal J Geiger, Krishna R Kalari, Daniel J Serie, Zhifu Sun, Alvaro Moreno-Aspitia, Daniel J O'Shannessy, Julia D Maltzman, Ann E McCullough, Barbara A Pockaj, Heather E Cunliffe, Karla V Ballman, E Aubrey Thompson, Edith A Perez

    Published 2015-01-01
    Get full text
    Article
  16. 16
    Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors.

    Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors. by Brian M Necela, Jennifer A Crozier, Cathy A Andorfer, Laura Lewis-Tuffin, Jennifer M Kachergus, Xochiquetzal J Geiger, Krishna R Kalari, Daniel J Serie, Zhifu Sun, Alvaro Moreno-Aspitia, Daniel J O'Shannessy, Julia D Maltzman, Ann E McCullough, Barbara A Pockaj, Heather E Cunliffe, Karla V Ballman, E Aubrey Thompson, Edith A Perez

    Published 2015-01-01
    Get full text
    Article
  17. 17
    An integrated model of the transcriptome of HER2-positive breast cancer.

    An integrated model of the transcriptome of HER2-positive breast cancer. by Krishna R Kalari, Brian M Necela, Xiaojia Tang, Kevin J Thompson, Melissa Lau, Jeanette E Eckel-Passow, Jennifer M Kachergus, S Keith Anderson, Zhifu Sun, Saurabh Baheti, Jennifer M Carr, Tiffany R Baker, Poulami Barman, Derek C Radisky, Richard W Joseph, Sarah A McLaughlin, High-seng Chai, Stephan Camille, David Rossell, Yan W Asmann, E Aubrey Thompson, Edith A Perez

    Published 2013-01-01
    Get full text
    Article
  18. 18
    Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial

    Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial by Pooja P. Advani, Kathryn J. Ruddy, Joerg Herrmann, Jordan C. Ray, Emily C. Craver, Greg Yothers, Greg Yothers, Reena S. Cecchini, Reena S. Cecchini, Corey Lipchik, Huichen Feng, Priya Rastogi, Priya Rastogi, Eleftherios P. Mamounas, Eleftherios P. Mamounas, Sandra M. Swain, Sandra M. Swain, Charles E. Geyer, Charles E. Geyer, Norman Wolmark, Norman Wolmark, Soonmyung Paik, Katherine L. Pogue-Geile, Gerardo Colon-Otero, Edith A. Perez, Nadine Norton

    Published 2023-05-01
    Get full text
    Article
  19. 19
    Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

    Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials by Saranya Chumsri, Zhuo Li, Daniel J. Serie, Nadine Norton, Afshin Mashadi-Hossein, Kathleen Tenner, Heather Ann Brauer, Sarah Warren, Patrick Danaher, Gerardo Colon-Otero, Ann H. Partridge, Lisa A. Carey, Florentine Hilbers, Veerle Van Dooren, Eileen Holmes, Serena Di Cosimo, Olena Werner, Jens Bodo Huober, Amylou C. Dueck, Christos Sotiriou, Cristina Saura, Alvaro Moreno-Aspitia, Keith L. Knutson, Edith A. Perez, E. Aubrey Thompson

    Published 2022-05-01
    Get full text
    Article
  20. 20
    Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer

    Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer by Jodi M. Carter, Saranya Chumsri, Douglas A. Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh, David W. Hillman, Kathleen S. Tenner, Jennifer M. Kachergus, Heather Ann Brauer, Sarah E. Warren, David Henderson, Ji Shi, Yi Liu, Heikki Joensuu, Henrik Lindman, Roberto A. Leon-Ferre, Judy C. Boughey, Minetta C. Liu, James N. Ingle, Krishna R. Kalari, Fergus J. Couch, Keith L. Knutson, Matthew P. Goetz, Edith A. Perez, E. Aubrey Thompson

    Published 2023-04-01
    Get full text
    Article

Search Tools: